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DOI 10.1016/j.devcel.2010.06.003SUMMARY 2008), and the maintenance of internal cell polarity relies onCell polarity plays a key role in the development of the
central nervous system (CNS). Interestingly, disrup-
tion of cell polarity is seen in many cancers. ASPP2
is a haplo-insufficient tumor suppressor and an acti-
vator of the p53 family. In this study, we show that
ASPP2 controls the polarity and proliferation of
neural progenitors in vivo, leading to the formation
of neuroblastic rosettes that resemble primitive
neuroepithelial tumors. Consistent with its role in
cell polarity, ASPP2 influences interkinetic nuclear
migration and lamination during CNS development.
Mechanistically, ASPP2 maintains the integrity of
tight/adherens junctions. ASPP2 binds Par-3 and
controls its apical/junctional localization without
affecting its expression or Par-3/aPKCl binding.
The junctional localization of ASPP2 and Par-3 is
interdependent, suggesting that they are prime tar-
gets for each other. These results identify ASPP2
as a regulator of Par-3, which plays a key role in
controlling cell proliferation, polarity, and tissue
organization during CNS development.
INTRODUCTION
Cell polarity is an evolutionarily conserved process that controls
cell differentiation, proliferation, and morphogenesis in both uni-
cellular and multicellular organisms. Genetic analysis of model
organisms such as Caenorhabditis elegans and Drosophila has
shown that three polarity complexes and an apical-junctional
complex (AJC) play a central role in the establishment and main-
tenance of apical-basal polarity. In epithelial tissues, the apical
and basolateral domains are separated by an AJC that is consti-
tuted of tight and adherens junctions (Hartsock and Nelson,126 Developmental Cell 19, 126–137, July 20, 2010 ª2010 Elsevier Inthis segregation. Two of the polarity complexes involved,
Crumb/Pals1/Patj and Par-3/aPKC/Par-6 (also called the Par
complex), localize at the apical membrane domain (Margolis
and Borg, 2005; Suzuki and Ohno, 2006) and their function is
antagonized by a third, basolaterally localized polarity complex
Scrib/Dlg/Lgl (Bilder, 2004).
Studies in Drosophila and transgenic mice have shown that
components of polarity complexes and AJC not only play key
roles in neurogenesis, neuronal migration, and axon extension
during the development of the CNS, but also function as mito-
gens. ASPP2 has been identified as a haplo-insufficient tumor
suppressor in mice (Vives et al., 2006) and belongs to the
ASPP family of proteins, which consists of three members:
ASPP1, ASPP2, and iASPP. The ASPP family of proteins is char-
acterized by a common C-terminal sequence: ankyrin repeats,
SH3 domain, and proline-rich region containing protein (Sullivan
and Lu, 2007). The best known function of ASPP2 is its binding to
p53, p63, and p73, and the stimulation of their apoptotic func-
tions by selectively enhancing their DNA binding and transacti-
vation activities on pro-apoptotic genes such as BAX and PIG3
(Bergamaschi et al., 2004; Samuels-Lev et al., 2001). In the
past decade, ASPP2 has also been identified as a binding
partner of a number of other proteins (Sullivan and Lu, 2007).
ASPP2 may, therefore, integrate different signaling pathways
to safe-guard normal development and suppress tumor growth.
To investigate this possibility, we carried out a detailed analysis
of CNSdefects inASPP2Dexon3mice and, in doing so, revealed
what we believe to be a novel function of ASPP2 in controlling
cell polarity and cell proliferation during CNS development.RESULTS
ASPP2 Plays a Key Role in CNS Development
To understand the biological functions of ASPP2, we deleted
exon 3 of the murine ASPP2 gene as described previously (Vives
et al., 2006). Approximately 30% of the ASPP2 Dexon3 pupsc.
Figure 1. Histological Abnormalities in the Brain and Retina of
ASPP2 Dexon3 Mice
(A and B) In whole mounts, ASPP2 transcripts start to be expressed at E9.5
and are prominent in the ventral neural tube, first brachial arch, and forelimb.
(C) The control sense probe gives no specific hybridization signal. Scale bar =
1 mm.
(D–F) H&E staining of the retinas. The retinal precursor cells in ASPP2 Dexon3
mice are no longer radially oriented and form rosette-like structures (E). The
square in (E) is enlarged in (F) and represents a rosette. Scale bar = 10 mm.
(G–I) Coronal sections ofASPP2wild-type andDexon3mice. Abnormal growth
of the neuroepithelium is observed in ASPP2 Dexon3 embryos with differing
degrees of severity (H and I). The asterisk indicates areas of abnormal growth.
Scale bar = 1 mm.
(J and K) Ganglionic eminences of ASPP2 wild-type and Dexon3 mice. The
cytoarchitecture of the neuroepithelium is also disorganized, and the polarity
of progenitor cells is lost (K). Scale bar = 10 mm.
All data presented in this figure were obtained in a J129/57BL6 background at
E13.5. GE, ganglionic eminence. (See also Figure S1 and Table S1.)
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determine the stage(s) of development affected by ASPP2,
fetuses were obtained from timed matings of heterozygotes.
ASPP2 Dexon3 embryos occurred at the expected 25%
frequency from E15.5 to E18.5 (see Table S1 available online).
The body size of ASPP2 Dexon3 surviving pups was generally
1.5–2 times smaller than that of wild-type and heterozygous
littermates. Gross and histological analysis of ASPP2 Dexon3
pups at P5-P10 (n = 4), P11-P20 (n = 5), and P21-P30 (n = 3)
showed a 100% incidence of hydrocephalus, consistent with
the domed head shape observed (Vives et al., 2006). The ventri-
cles of the newborn ASPP2 Dexon3 animals appeared to be
drastically dilated, and the subventricular structures were
damaged severely (Figure S1A). The retinas of the ASPP2
Dexon3 pups were also abnormal, the commonest defect being
bilateral retinal dysplasia, in which the photoreceptor and outer
nuclear layers exhibit dysplastic rosettes (Figures S1B–S1F).
These rosettes were similar to those observed in human
tumors of neuronal origin (Graham et al., 2002; Sangueza
et al., 1994).
Because the mixed background ASPP2 Dexon3 pups were
born at a significantly reduced rate (6%) and all died before
weaning (Vives et al., 2006), we generated ASPP2 Dexon3
mice in a Balb/c background by backcrossing. The resulting
ASPP2 Dexon3 mice were born according to Mendelian segre-
gation, and the majority survived after weaning (data not shown).
Interestingly, all of the Balb/c background ASPP2 Dexon3 mice
similarly developed hydrocephalus and retinal dysplasia (data
not shown). These data suggest that ASPP2 plays a key role in
CNS development.
To further understand howASPP2 controls CNSdevelopment,
we examined ASPP2 mRNA expression by whole-mount in situ
hybridization in midgestation embryos. Although ASPP2 mRNA
was not expressed at E8.5 (Figure 1A), transcripts were detected
from E9.5 onward (Figure 1B). No signal was detected when the
sense probe was used as a negative control (Figure 1C). As
expected, ASPP2 mRNA was expressed strongly in the brain,
spinal cord, and optic cup.
Histological analysis of ASPP2 Dexon3 embryos carried out at
E13.5 showed extensive morphological abnormalities in the
retina and brain, which were not found in heterozygous embryos
(data not shown). These abnormalities were common to all
ASPP2 Dexon3 embryos, regardless of their background.
In the wild-type retina, retinal precursor cells (RPCs) were
arranged radially along the apical basal axis (Figure 1D). In con-
trast, the RPCs in the central region of the ASPP2 Dexon3 retina
had lost their normal orientation and formed rosette-like struc-
tures (Figures 1E and 1F). In comparison to the wild-type (Fig-
ure 1G), abnormal growth of neuroepithelial cells was also
observed, either at the level of the third ventricle (Figure 1H) or
throughout the brain (Figure 1I). In addition, the normal radial
orientation of progenitors was lost in the ganglionic eminence
of ASPP2 Dexon3 embryos. In contrast to control embryos,
where the ventricular zone (VZ) was columnar and pseudostrati-
fied (Figure 1J), cells in the VZ of ASPP2 Dexon3 embryos were
disorganized, less columnar, and protruded into the ventricles
(Figure 1K). Rosette-like structures, similar to those observed
in the retina, were also detected in the abnormally growing neu-
roepithelium (data not shown).DeveDeregulated cell growth and loss of organization of the neuro-
epithelium was also detected in Balb/c embryos and was there-
fore not background dependent (Figures S1G–S1J), although the
extent of abnormal cell growth was less dramatic in Balb/c than
in the mixed background. The majority of Balb/c ASPP2 Dexon3
embryos only exhibited abnormal cell growth in the third ven-
tricle (Figures S1G and S1H, boxed region). Collectively, these
results illustrate that ASPP2 plays an important role in maintain-
ing the structural organization of the neuroepithelium, and
controlling the growth of neural progenitor cells.lopmental Cell 19, 126–137, July 20, 2010 ª2010 Elsevier Inc. 127
Figure 2. ASPP2 Inhibits Neural Progenitor Prolif-
eration
P-H3 immunostaining of coronal sections of ASPP2 wild-
type and Dexon3 neural tubes at (A and B) E11.5 and
(C and D) E13.5. (E) Quantification of the mitotic index,
defined as the ratio of mitotic cells (P-H3+) to total cell
number (TO-PRO staining). n, number of embryos. Mitotic
cells are scattered throughout the neuroepithelium in
ASPP2 Dexon3 embryos (white arrows in [B] and [D]).
Nestin immunostaining of E13.5 coronal sections of
(F and G) ASPP2 wild-type and (H and I) Dexon3 embryos
shows expansion of the progenitor cell population in
ASPP2 Dexon3 embryos (G and I).
(A–D) Scale bar = 10 mm.
(F–I) Scale bar = 1 mm.
All the data presented in this figure were obtained in
a J129/57BL6 background. PH-3, phospho-histone
H3 (see also Figure S2). Standard deviations: E11.5
ASPP2+/+ 1.5 ± 0.3; E11.5 ASPP2 Dexon3 3 ± 0.2;
E13.5 ASPP2+/+ 2.1 ± 1; and E13.5 ASPP2 Dexon3
5.2 ± 0.8.
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One of the main phenotypes of ASPP2 Dexon3 mice is deregu-
lated neuroepithelial growth. To determine whether the loss of
ASPP2 leads to changes in cell proliferation, an anti-phos-
pho-H3 (P-H3+) antibody was used to identify mitotic cells
(Figures 2A–2D). The mitotic index, defined as the ratio of
mitotic cells (P-H3+) to total cell number, revealed an 2- to
2.5-fold increase in the percentage of mitotic cells at E11.5
and E13.5 in ASPP2 Dexon3 neural tubes, in comparison to
wild-type embryos (Figure 2E). In ASPP2 wild-type E13.5
embryos, nestin-expressing neural progenitors (Hockfield and
McKay, 1985) were only detected in the VZ of the telenceph-
alon (Figures 2F and 2G). In ASPP2 Dexon3 embryos, however,
the highly proliferative neural progenitors were spread
throughout the proliferating neuroepithelium (Figures 2H and
2I). Similar results were obtained with the progenitor marker
Ki67 (Hartfuss et al., 2001) (data not shown). These results
suggest that there is an expansion of neural progenitors in
ASPP2 Dexon3 embryos.
Enlargement of the neural progenitor pool in ASPP2 Dexon3
embryos could be caused by shortening of the cell cycle,
reduced apoptosis, or a combination of both. As the ratio
between the BrdU-positive and Ki67-positive cells provides an
estimate of cell cycle length in neural progenitors (Chenn and
Walsh, 2002), cell cycle length in ASPP2 wild-type and Dexon3
brains was measured by analyzing the proportion of neural
progenitors labeled by BrdU after a 30 min pulse over Ki67-posi-
tive neural progenitors in E 13.5 ganglionic eminences (Figures
S2A and S2B). A 2-fold increase in the percentage of BrdU-posi-
tive cells was observed in ASPP2 Dexon3 over wild-type brains
(Figure S2C). Because a larger percentage of BrdU-positive
cells indicates a shortening of the cell cycle, this result suggests
that there is a cell cycle shortening in ASPP2 Dexon3 neural
progenitors.128 Developmental Cell 19, 126–137, July 20, 2010 ª2010 Elsevier InASPP2 is known to enhance p53-mediated apoptosis. We
thus examined whether there is an apoptotic defect in ASPP2
Dexon3 brains. Apoptotic cells were labeled with an anti-active
Caspase 3 antibody, and the number of apoptotic cells com-
pared between wild-type and ASPP2 Dexon3 embryos, in simi-
larly sized areas of the brain (Figures S2D and S2E, boxed
area). Interestingly, the number of apoptotic cells detected in
ASPP2 Dexon3 embryos was higher than that detected in the
wild-type (Figures S2F and S2G). This indicates that the exces-
sive growth of neural progenitors observed in ASPP2 Dexon3
embryos was not caused by a lack of apoptosis.
ASPP2 Affects Interkinetic Nuclear Migration
To establish whether the disorganization of the neuroepithelium
observed in ASPP2 Dexon3 mice impacts the organization of
highly laminated structures, the cortices of ASPP2 Dexon3
mice were analyzed at E14.5, when neurogenesis reaches its
peak. As severe expansion of neuroepithelia throughout the
brain is often observed in ASPP2 Dexon3 embryos in the mixed
129/C57BL6 background, preventing the identification of dif-
ferent structures in the forebrain, the cortex could only be
analyzed in Balb/c background embryos. In the wild-type,
mitotic cells were found mostly at the ventricular surface and
only a small minority found in the nonsurface area of the ventric-
ular and subventricular zones (Figure 3A). In contrast, only a small
proportion of mitotic cells were found at the ventricular surface in
the neocortex of ASPP2 Dexon3 embryos, with almost half of
them scattered up to the cortical plate (CP) (Figure 3B).
During each cell cycle, progenitor cells undergo a distinctive
pattern of oscillation in the VZ, termed interkinetic nuclear migra-
tion. Cells go through S-phase at the basal surface of the VZ,
and mitosis at the apical surface (Rakic and Goldman-Rakic,
1982). The mislocalized mitotic cells observed in ASPP2mutant
embryos suggest that ASPP2 may play a role in controllingc.
Figure 3. ASPP2 Affects Interkinetic Nuclear Migration and Lamina-
tion of the Neocortex
(A–H) P-H3 immunostaining of coronal sections of ASPP2 wild-type and
Dexon3 cortices (A and B). Although mitotic cells were found mainly at the
ventricular surface in control embryos (A), only a small proportion were found
in this area inASPP2Dexon3 embryos, with themajority in the nonsurface area
of the VZ (arrows in [B]). Distribution of BrdU-positive cells (green) after a (C
and D) 30 min, (E and F) 3 hr, or (G and H) 6 hr BrdU single pulse in ASPP2+/+
and Dexon3 cortices at E14.5. TO-PRO (blue) was used as a counterstain.
Scale bar = 10 mm.
(I–R) Analysis of interkinetic nuclear migration. Standard deviation: 3 hr
ASPP2+/+, 19 ± 0.8; 3 hr ASPP2 Dexon3, 14 ± 0.08; 6 hr ASPP2+/+, 27 ± 2;
and 6 hr ASPP2 Dexon3, 15 ± 1. Percentage of BrDu-positive nuclei at the
apical position identified in a 10 mmhigh area (dashed lines in E–H). Lamination
of the neocortex is affected in ASPP2 Dexon3 embryos (J–R). (J and K) Pax6
and (L and M) Tbr2 immunostaining of ASPP2 wild-type and Dexon3 cortices.
Pax6 staining, only present in the VZ in the control, is detected in the SVZ
(black arrow in [K]) in the ASPP2 Dexon3 cortex. Tbr2 staining, restricted to
the VZ and SVZ in the control, is detected in the IZ in the mutant (white arrows
in M). bIII-tubulin immunostaining of coronal (N–P) ASPP2wild-type and (O–Q)
Dexon3 cortices at E14.5. The squares (N and O) represent higher magnifica-
tion views of the VZ (P and Q). Although only a few neuronal projections are
found in the wild-type VZ (arrow in [P]), somata of neurons are detected in
the VZ of ASPP2 Dexon3 embryos (arrows in [Q]). (R) Percentage of bIII-
tubulin-positive cells in ASPP2+/+ and Dexon3 cortices at E14.5. Scale bar =
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Deveinterkinetic nuclear migration (INM) of neural progenitors. To
analyze INM in the ASPP2 Dexon3 cortex, females pregnant
from an ASPP2 heterozygous mating were injected at E14.5
with a single pulse of BrdU, and sacrificed after 30 min (Figures
3C and 3D), 3 hr (Figures 3E and 3F), or 6 hr (Figures 3G and 3H).
The number of BrdU-positive nuclei at the apical side of the VZ
was divided by the total number of BrdU-positive cells identified
in a 10 mm high area, after a 3 or 6 hr pulse (Figures 3E–3H,
dashed line), to estimate INM (Cappello et al., 2006). The per-
centage of cells detected at the apical side was 14% ± 0.08%
and 15% ± 1% in the ASPP2 Dexon3 cortex, compared to
19% ± 0.8% and 27% ± 2% in the ASPP2wild-type cortex, after
3 and 6 hr BrdU pulses, respectively (Figure 3I). The clear reduc-
tion in the percentage of BrdU-positive cells at the apical side of
ASPP2 Dexon3 cortices, in comparison with ASPP2+/+ cortices,
indicates a defect in INM in ASPP2 mutant embryos.ASPP2 Controls Lamination of the Neocortex and Retina
Pax6 is a homeodomain transcription factor expressed in apical
progenitors, and Pax6-positive nuclei accumulate in the VZ of
the normal cortex (Englund et al., 2005; Gotz et al., 1998). In
contrast, Tbr2 (T-box brain 2) is a transcription factor expressed
by intermediate progenitor cells (IPCs) in the subventricular zone
(SVZ) during development (Englund et al., 2005). To provide
further evidence that ASPP2 controls the position of neural
progenitors, the distribution of Pax6- or Tbr2-expressing apical
and basal progenitor cells was analyzed in the neocortex.
Whereas Pax6- and Tbr2-positive cells were only found in the
VZ or SVZ, respectively, in ASPP2 wild-type embryos (Figures
3J and 3L), they were scattered outside these regions in
ASPP2 Dexon3 neocortices (Figures 3K and 3M, arrows).
Cortical neurons arise from the proliferative pseudostratified
epithelium, at the margin of embryonic cerebral ventricles (Rakic
and Goldman-Rakic, 1982). As cortical development proceeds,
progenitor cells exit the cell cycle, begin to differentiate into
neurons, and migrate out of the VZ toward their final resting
place in the developing cortex. This movement of cells from
the VZ to the outer surface of the brain is called radial migration.
As progenitor cells were displaced in ASPP2 Dexon3 neocorti-
ces, the distribution of bIII tubulin-expressing postmitotic neu-
rons was also analyzed. In wild-type embryos, bIII tubulin-
expressing postmitotic neurons were found at the outer margin
of the cortex (Figure 3N). In the VZ only neuronal projections
were identified (Figure 3P, arrows). However, In ASPP2 Dexon3
embryos, bIII tubulin-positive neuronal bodies were found in the
VZ (Figure 3O and Figure 3Q, arrows), suggesting a possible
defect in radial migration. Quantification of the percentage of
bIII tubulin-positive cells in ASPP2+/+ and Dexon3 cortices (Fig-
ure 3R) shows an overall reduction in the number of differentiated
neurons in ASPP2 Dexon3 cortices, suggesting that ASPP2 may
play a role in regulating neuronal differentiation during CNS
development.10 mm. Standard deviation: ASPP2+/+, 52 ± 2.8; ASPP2 Dexon3, 37 ± 1.4.
TO-PRO (blue) was used as a counterstain.
All the data presented in this figure were obtained in a Balb/c background at
E14.5. CP, cortical plate; IZ, intermediate zone; PH-3, phospho-histone H3;
SVZ, subventricular zone; VZ, ventricular zone. (See also Figure S3.)
lopmental Cell 19, 126–137, July 20, 2010 ª2010 Elsevier Inc. 129
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nation, markers of early- (Foxp2 and Er81) and late-born neurons
(SMI32) were used to analyze lamination of postnatal P15ASPP2
wild-type and Dexon3 cortices. Although Er81- and Foxp2-
expressing early-born neurons were detected in the correct
layers in both wild-type and mutant cortices (Figures S3A–
S3D), SMI32-expressing late-born neurons were mislocalized
in the mutant cortex (Figures S3E and S3F). These results illus-
trate that ASPP2 may play a role in controlling lamination of the
neocortex. It may also have an impact on the differentiation
program of some cortical neurons.
The effect of ASPP2 on lamination was further analyzed in the
retina, another highly laminated structure. A severe disruption of
lamination in P15 retinas was observed in ASPP2 Dexon3 mice
using several markers for rods (rhodopsin), Muller glia (CRALBP),
horizontal and retinal ganglionic cells (neurofilament 160), ama-
crine and retinal ganglionic cells (Pax6), and cones (calbindin).
Although all cell types were present in the ASPP2 Dexon3 retina,
they were mislocalized (Figures S3G–S3P). These results sug-
gest that ASPP2 is required for proper neuronal differentiation
and organization of highly laminated structures of the CNS,
such as the cortex and the retina.Figure 4. ASPP2 Colocalizes with Components of the Apical Polarity
Complex and AJC In Vivo
(A–C) Images of E13.5 neuroepithelia of the ganglionic eminence coimmunos-
tained with antibodies against (A) Par-3, (B) ZO-1, and (C) b-catenin (red) and
ASPP2 (green).
(D) Diagram illustrating the subcellular localization of Par-3, ZO-1, b-catenin,
and ASPP2 in polarized neuroepithelial cells.
(E–H) aPKC (E and F) and b-catenin (G and H) immunostainings of ASPP2+/+ or
Dexon3 ganglionic eminences show a clear loss of apical polarity. The normal
apical localization of aPKC and b-catenin in the wild-type is massively disrup-
ted in ASPP2 Dexon3 neuroepithelia (white arrows in [F] and [H]). TO-PRO
(blue) was used as a counterstain.
Scale bars = 10 mm and 500 nm (A–C); 10 mm (E–H). All the data presented in
this figure were obtained in a J129/57BL6 background at E13.5 GE, ganglionic
eminence (see also Figure S4).ASPP2 Colocalizes with Components of the Par
Complex and AJC In Vivo
Polarity is a feature of epithelial cells, which is defined by an
apical surface facing the external environment separated from
the basolateral surface by the AJC. The integrity of AJC and
the Par-3/aPKC/Par-6 complex (the Par complex) are critical
for the establishment and maintenance of cell polarity in epithe-
lial tissues. Because the neuroepithelium is disorganized in
ASPP2 Dexon3 embryos, we hypothesized that ASPP2 may
control cell polarity by interacting with components of the Par
complex and AJC. We examined the expression patterns of
ASPP2 in neural epithelia and observed that ASPP2 locates
apically in the E13.5 ganglionic eminence and cortex (Figures
S4A–S4C), where components of the Par complex and AJC
are localized. The similarities in the expression patterns of
ASPP2 and the Par complex proteins led us to analyze the local-
ization of Par-3 and ASPP2. Interestingly, ASPP2 colocalized
extensively with Par-3 at the apical side of the neuroepithelium
(Figure 4A). Furthermore, ASPP2 also colocalized with ZO-1,
which is known to colocalize with Par-3 (Bultje et al., 2009)
(Figure 4B). However, ASPP2 only partially colocalized with the
adherens junction component b-catenin, indicating that it is
enriched at the level of tight junctions where ZO-1 and Par-3
are expressed (Figure 4C). Figure 4D summarizes the localization
of ASPP2 in relation to Par-3 and AJC.
In ASPP2 wild-type neuroepithelia, both aPCK and b-catenin,
components of the Par complex and AJC, respectively, localized
predominantly apically (Figures 4E and 4G). In ASPP2 Dexon3
neuroepithelia, however, these two proteins were markedly
disorganized (Figures 4F and 4H). Similarly, disorganized b-cat-
enin was observed in the cortices of ASPP2 Dexon3 mice in the
Balb/c background (Figures S4D and S4E). ASPP2 may there-
fore control cell polarity through its ability to colocalize with,
and influence the cellular localization of, proteins of the Par
complex and AJC.130 Developmental Cell 19, 126–137, July 20, 2010 ª2010 Elsevier InASPP2 Maintains the Integrity of Tight Junctions In Vivo
The AJC consists of tight/adherens junctions and plays an
important role in maintaining the blood-cerebrospinal fluid
(CSF) barrier function of the choroid plexus, the disruption of
which can lead to hydrocephalus. Knowing that ASPP2 colocal-
izes with components of the AJC and that allASPP2mutantmice
suffer from hydrocephalus, we hypothesized that ASPP2 may
influence the integrity of the AJC of the choroid plexus. We first
tested whether ASPP2 colocalizes with components of the
AJC in the choroid plexus and, as expected, ASPP2 colocalizedc.
Figure 5. ASPP2 Maintains the Integrity of Tight Junctions In Vivo
(A–F) Images of E13.5 choroid plexus from ASPP2+/+ and Dexon3 mice, coimmunostained with antibodies against ZO-1 (red), and ASPP2 (green). Cross-section
(location indicated by broken line in [E]) is shown at base of image. Enlargement of area of cross section is indicated by dashed area. Note that ASPP2 largely
colocalizes with ZO-1 at the cellular apical domain (white arrow). Absence of ASPP2 in the choroid plexus causes delocalization of ZO-1 and aberrant morpho-
logical changes (B, D, and F). TO-PRO (blue) was used as a counterstain.
(G–L) Transmission electronmicroscopy of the choroid plexus of the fourth ventricle, from (G and I)ASPP2+/+ and (H, J, and K)Dexon3 littermates.ASPP2Dexon3
choroid plexus cells are small and balloon shaped, rather than cuboidal (G and H), and tight junctions at the apical pole are less electron-dense (I, J, and K).
A higher percentage of open junctions, as seen in (K), was also identified (L). Standard deviation: ASPP2+/+, 23 ± 5; ASPP2 Dexon3, 78 ± 2.
Scale bars = 28 mm, 10 mm, and 2.5 mm (A–F). Scale bar = 1 mm (G and H). Scale bar = 500 nm (I–K). CP, choroid plexus; n, number of mice for each genotype.
All the data presented in this figure were obtained in a Balb/c background (see also Figure S5).
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expression was also severely disrupted in the ASPP2 Dexon3
choroid plexus (Figures 5B, 5D, and 5F). The integrity of the
AJC was then investigated in ASPP2 Dexon3 pups with very
mild hydrocephalus in the Balb/c background using transmis-
sion electron microscopy. In ASPP2 wild-type pups, choroid
plexus cells were cuboidal and tightly connected by the AJC
(Figure 5G). In contrast, cells of the ASPP2 Dexon3 choroid
plexus were rounded and the epithelium was disorganized
(Figure 5H). The tight/adherens junctions between cells were
less electron-dense in ASPP2 Dexon3 pups when compared to
the wild-type (Figures 5I and 5J). Additionally, many of the
tight/adherens junctions at the apical poles of choroid plexus
cells failed to form tightly closed electron-dense junctions
(Figures 5K and 5L). These data support the notion that ASPP2
colocalizes with ZO-1 and maintains the integrity of tight
junctions in vivo.
To investigate further the subcellular localization of ASPP2, we
used a number of well-described epithelial cell systems. ASPP2
was first expressed exogenously in MCF7 cells and its expres-
sion patterns analyzed by immunostaining. Interestingly, in addi-
tion to its locations known previously (cytoplasm and nucleus)
(Samuels-Lev et al., 2001), ASPP2 was also detected at cell/
cell junctions (Figure S5A). In polarized MDCK cells, a canine
kidney epithelial cell line often used to study epithelial cell
polarity in vitro, we observed that ASPP2 was predominantlyDeveexpressed as a junctional protein and strongly colocalized
apically with both Par-3 and ZO-1 (Figures S5B–S5E). Further-
more, ASPP2 was mostly found apically of b-catenin (Figures
S5F and S5G). This expression pattern resembles that seen
in vivo, establishing polarized MDCK cells as a useful experi-
mental system for studying the function of junctionally localized
ASPP2 in cell polarity.
ASPP2 Affects Early Establishment
of Cell/Cell Junctions
The homophilic interaction between cadherins is calcium
dependent and essential in the formation of cell/cell junctions.
Low calcium levels disrupt cell/cell junctions and addition of
calcium can induce their formation. We, thus, used a calcium
switch assay to manipulate the cell/cell junctions of polarized
monolayers of MDCK cells, and investigate the cellular localiza-
tion of ASPP2 during their establishment. Interestingly, when
cell/cell junctions were disrupted by low calcium containing
medium, ASPP2 was found mainly to be diffused in the cyto-
plasm. Par-3, ZO-1, and b-catenin were also cytoplasmic under
the same conditions (Figure 6; data not shown). As early as
30 min after calcium addition, ASPP2 was detected together
with Par-3 at newly formed cell/cell contacts, suggesting that
they are recruited together. Similar results were observed
for ZO-1, but not for b-catenin, as ASPP2 seemed to be local-
ized more apically than b-catenin in newly formed cell/celllopmental Cell 19, 126–137, July 20, 2010 ª2010 Elsevier Inc. 131
Figure 6. ASPP2 and Par-3 Are Recruited Simultaneously to Newly Formed Cell/Cell Contacts in Polarizing MDCK Cells
Monolayers of polarized calcium-depleted MDCK cells were subjected to a calcium switch (CS), and immunostaining carried out at various time points, to
follow the recruitment of ASPP2 (green) and Par-3 (red) to newly formed cell/cell contacts in a time-dependent manner. Dotted lines represent locations of
cross sections. White arrow heads indicate colocalization between ASPP2 and Par-3 in nascent cell/cell contacts. DAPI was used to stain nuclei (see also
Figure S6).
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to newly formed cell/cell contacts in other cell lines including
MCF7 cells (data not shown). The early recruitment of ASPP2
together with Par-3 and ZO-1 to cell/cell contact sites during
the formation of cell/cell junctions suggests that ASPP2 may
regulate the formation of cell/cell junctions (Horikoshi et al.,
2009).
To test this hypothesis, primary kidney epithelial cells (PKECs)
were isolated from ASPP2 Dexon3 conditional mice. Both
b-catenin and E-cadherin were used to mark cell/cell contacts
(Figures S6A and S6B). E-cadherin and b-catenin were detected
mainly in the cytoplasm in both ASPP2+/+ and induced ASPP2
Dexon3 PKECs after exposure to low calcium medium for 2 hr
(Figures S6C and S6D). On calcium addition, cell/cell contacts
were re-established in ASPP2+/+ cells after 20 min (Figure S6E).
However, under the same conditions, very few cell/cell contacts
were detected in ASPP2 Dexon3 PKECs (Figure S6F). Interest-
ingly, 40 min after the addition of calcium, the cell junctions
formed in ASPP2 wild-type versus ASPP2 Dexon3 PKECs
were similar, as judged by the colocalization of E-cadherin and
b-catenin at cell/cell contacts (Figures S6G and S6H). The
observed delay, rather than total failure, of the formation of
mature cell/cell contacts in ASPP2 Dexon3 PKECs suggested
that ASPP2 is involved in the initial formation of cell/cell contacts.
This is in agreement with its ability to be recruited to cell/cell
contacts together with Par-3 at the earliest time points
examined.132 Developmental Cell 19, 126–137, July 20, 2010 ª2010 Elsevier InASPP2 Binds Par-3 and Their Junctional Localization
Is Interdependent
MDCK cells were used to investigate whether ASPP2 can bind to
components of the Par complex and AJC. Interestingly, when
ASPP2 was immunoprecipitated, Par-3 and, to a lesser extend
aPKCl, ZO-1, and b-catenin were all found to coimmunoprecipi-
tate. Under the same conditions, ZO-2 and Lgl could not be
detected (Figure 7A). To investigate this further, reciprocal coim-
munoprecipitations were carried out. Interestingly, ASPP2 was
only coimmunoprecipitated by the anti-Par-3 antibody, and not
by the anti-ZO1 and anti-b-catenin antibodies, confirming that
ASPP2 and Par-3 are binding partners (Figure 7B). Furthermore,
densitometric analysis of Figure 7A indicates that the ratio of
Par-3 coimmunoprecipitating with ASPP2 was greater than
that of ZO-1, b-catenin, and aPKCl (Figure 7C). The existence
of an ASPP2/Par-3 complex was further examined in vivo using
ASPP2 wild-type brain lysates and confirmed by a reciprocal
immunoprecipitation assay (Figure 7D).
Knowing that ASPP2 binds to and colocalizes with Par-3, we
analyzed the ability of ASPP2 to influence the location of Par-3
in a newly established 3D culture model system using PKECs
isolated from ASPP2 Dexon3 conditional mice, similar to that
described for MDCK cells (Elia and Lippincott-Schwartz, 2009).
After 3 days in culture, mouse PKECs formed small polarized
cysts consisting of a few cells, with apical Par-3 and basolateral
E-cadherin (Figure 7E). In this model system,most of the ASPP2-
expressing cysts exhibited apical Par-3, whereas it was notc.
Figure 7. ASPP2 Binds to Par-3 and Is Required for
Its Correct Localization
(A–C) The interaction between ASPP2 and various polarity
or cell/cell junction proteins was tested in MDCK cells. (A)
Endogenous ASPP2 was immunoprecipitated with anti-
ASPP2 rabbit polyclonal antibody (S32) and anti-Gal4
rabbit polyclonal antibody used as a negative control.
ASPP2, Par-3, aPKCl, b-catenin, ZO-1, ZO-2, and Lgl
were detected by SDS-Page/immunoblotting. (B) Recip-
rocal coimmunoprecipitations were carried out to further
investigate the binding of ASPP2 to Par-3, ZO-1, and
b-catenin. (C) The bar graph represents the relative
binding of ASPP2 to Par-3, ZO-1, b-catenin, and aPKCl.
(D) The interaction between ASPP2 and Par-3 was tested
in vivo using mouse brain lysate.
(E) The subcellular localization of Par-3 (red) and E-cad-
herin (green) was analyzed by immunostaining during cys-
togenesis in ASPP2+/+ or induced Dexon3 mouse tubular
kidney epithelial cells. White arrow heads show apical
Par-3 at the edge of forming lumens. DAPI (blue) was
used to stain nuclei.
(F) ASPP2 and Par-3, respectively, were depleted in Hke-3
cells using siRNA and immunostaining for ASPP2, Par-3,
ZO-1, and b-catenin was carried out. RISC Free was
used as a negative control. The effect of ASPP2 on
Par-3/aPKCl binding was investigated both (G) in vitro in
HKe-3 cells using siRNA oligos against human ASPP2,
and (H) in vivo using ASPP2+/+ or Dexon3 mouse brain
lysate. u, untransfected. (See also Figure S7.)
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These results suggest that ASPP2 is required for the apical local-
ization of Par-3.
To further explore the biological implications of the ASPP2/
Par-3 interaction, the influence of ASPP2 on the localization of
Par-3 was tested in HKe-3 cells, a human epithelial colon cancer
cell line (Shirasawa et al., 1993), in which ASPP2 is predomi-
nantly expressed at cell/cell junctions. ASPP2 RNAi resulted in
a drastic reduction of junctionally expressed Par-3, ZO-1, and
b-catenin (Figure 7F). Importantly, ASPP2 RNAi reduced the
expression level of ASPP2 but had a minimal effect on that of
Par-3 (Figure 7G), ZO-1, and b-catenin (data not shown). Inter-
estingly, RNAi of Par-3 did not affect the junctional localization
of b-catenin and only caused the cytoplasmic relocation of
ASPP2 and ZO-1, suggesting that disruption of Par-3 might
provide an opportunity to investigate whether tight/adherens
junction formation can be uncoupled from the ASPP2/Par-3
interaction.Developmental Cell 19To address this issue, we used a YFP-tagged
Par-3 fragment that contains the oligomeriza-
tion domain of Par-3 [YFP-Par-3(N-Term)] to
interfere with endogenous Par-3 localization,
because Par-3 is normally an oligomer (Benton
and St. Johnston, 2003; Traweger et al., 2008).
It is important to note that the epitopes of the
anti-Par-3 antibody used in this study are
located outside this region of Par-3 (residues
457–744 of mouse Par-3). Thus, we were able
to detect the effect of YFP-Par-3(N-term) on
endogenous Par-3. The expression of YFP-
Par-3(N-term) induced cytoplasmic relocaliza-tion of endogenous Par-3 in transfected MDCK cells. Interest-
ingly, junctional staining for ASPP2 was absent in YFP-Par-3
(N-term) expressing cells (Figure S7A). This is in contrast to the
junctional localization of Par-3 and ASPP2 detected in untrans-
fected cells (Figure S7A) or in cells transfected with YFP alone
(data not shown). Importantly, the expression of YFP-Par-3
(N-term) had little effect on the junctional localizations of ZO-1
and b-catenin (Figure S7B). This experimental system is there-
fore less disruptive to tight junction than that of Par-3 RNAi
(Figure 7F) (Chen and Macara, 2005) and has provided us with
an opportunity to investigate whether the ability of ASPP2 and
Par-3 to control the junctional localization of each other requires
the initiation of tight junction formation.
To explore this, a calcium switch assay was carried out in
MDCK cells. ZO-1 was recruited to the cell/cell junctions as early
as 30 min after the switch in YFP-Par-3(N-term) negative cells,
but not in YFP-Par-3(N-term) positive cells. Two hours after
calcium addition (Figure S7C), YFP-Par-3(N-term) expressing, 126–137, July 20, 2010 ª2010 Elsevier Inc. 133
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remained cytoplasmic in YFP-Par-3(N-term) positive cells.
Residual junctional ASPP2 was only detected in YFP-Par-3
(N-term) negative cells. Both endogenous ASPP2 (Figure S7C)
and Par-3 (data not shown) failed to be recruited to the newly
formed cell-cell junctions even 5 hr after calcium addition in
YFP-Par-3(N-term) expressing cells, despite the fact that junc-
tional ZO-1 was detected in all of them. These data show that
ASPP2/Par-3 can bind and control the cellular localization of
each other, suggesting that ASPP2 and Par-3 are prime targets
for each other.
To gain further understanding about the domains of Par-3 that
are involved in the interaction with ASPP2, YFP-tagged frag-
ments of Par-3 were coexpressed with full-length ASPP2 in
MDCK cells (Figure S7D) (Traweger et al., 2008). Interestingly,
a relatively large portion of Par-3 spanning the PDZ domain
3 and a C-terminal region containing the aPKC and partial
TIAM1 binding regions was found to coimmunoprecipitate with
ASPP2. Remarkably, the ASPP2 binding region of Par-3
happens to be similar as that shown previously by Chenn and
Walsh (2002) to be important in rescuing tight junction formation
in Par-3-depleted cells independently of aPKC or Par-6 binding.
aPKC forms a stable complex with Par-6, and Par-3 has been
shown to induce the formation of a tripartite complex with aPKC
and Par-6 (Suzuki et al., 2001; Yamanaka et al., 2001). Any
impact of the activity of ASPP2 on aPKC via Par-3 will, therefore,
likely be reflected on Par-6; thus, we focused our attention on
investigating the ability of ASPP2 to influence Par-3/aPKCl
binding. Interestingly, we observed that although Par-3 binds
ASPP2 effectively in Hke-3 cells, the expression level of
ASPP2 has no impact on Par-3/aPKCl binding. Similar amounts
of Par-3/aPKCl complexes were detected in Hke-3 cells with or
without ASPP2 RNAi expression (Figure 7G). The failure of
ASPP2 to influence Par-3 expression or Par-3/aPKCl binding
was also confirmed in vivo using lysates derived from ASPP2
wild-type and Dexon3 brains (Figure 7H). ASPP2 thus has
minimal impact on the expression level of Par-3 and Par-3/
aPKCl interaction in the experimental systems tested.
Collectively, our results show that ASPP2 is a binding partner
of Par-3, required for its apical/junctional localization without
affecting its expression level. The region of Par-3 corresponding
to its binding region to ASPP2 is known to be critical in control-
ling tight junction assembly independently of aPKC and Par-6.
Thus, the identified ASPP2/Par-3 complex is likely to play a posi-
tive role in influencing the ability of Par-3 to locate at cell/cell
junctions and controlling tight junction maturation. Binding to
Par-3 and controlling its cellular localization might, therefore,
be a mechanism by which ASPP2 maintains the integrity of tight
junctions and cell polarity in vitro and in vivo.
DISCUSSION
We believe we have identified the tumor suppressor ASPP2 as
a binding partner of Par-3 and a key player in controlling cell
polarity and the proliferation of neural progenitors during CNS
development. Par-3 is a component of the Par complex and
has critical functions in the assembly of tight junctions (Chen
and Macara, 2005). The AJC complex, which consists of tight/
adherens junctions, has a crucial role inmaintaining the segrega-134 Developmental Cell 19, 126–137, July 20, 2010 ª2010 Elsevier Intion between the apical and basolateral domains and therefore
cell polarity. We suggest our results show that ASPP2 is required
in vivo to maintain the integrity of tight junctions and is recruited
in vitro with Par-3 to cell/cell contacts. Furthermore ASPP2 and
Par-3 bind and control each other’s cellular localization in vitro,
illustrating that ASPP2 and Par-3 are prime targets for each
other.
The tripartite Par-3/aPKC/Par-6 complex is dynamic. In cells,
aPKC forms a stable complex with Par-6, but Par-3 does not
always complex with them. Although Par-3 is required for the
apical localization of aPKC/Par-6, it can control tight junction
assembly independently of them (Chen and Macara, 2005).
Furthermore, as not all Par-3 proteins locate at the apical
membrane domains or tight junctions, the molecular mecha-
nisms that control their location are important to our under-
standing of cell polarity. Our finding that ASPP2 controls the
location of Par-3 without affecting Par-3/aPKCl interaction
suggests that ASPP2/Par-3 binding is likely to function indepen-
dently of the PAR3/aPKC complex. Additionally, Par-3 is unlikely
to be the only target of ASPP2, as RNAi of ASPP2 disrupted both
tight and adherens junctions, whereas RNAi of Par-3 only disrup-
ted the former. These findings may explain why ASPP2 mutant
mice do not have the same phenotype as that observed after
depletion of Par-3 with shRNA, which causes premature differ-
entiation of progenitors (Bultje et al., 2009).
The finding that Par-3 interacts with ASPP2 through a C-termi-
nal region, encompassing its PDZ domain 3 and the aPKC and
TIAM1 binding regions, is of particular interest as the same
C-terminal region has been shown to be able to partially rescue
junction assembly. Furthermore, this function of Par-3 requires
neither Par-6 nor aPKC binding (Chen and Macara, 2005). This
is consistent with our finding that ASPP2 is important for cell
polarity and junction assembly, and that ASPP2 does not inter-
fere with the Par-3/aPKC interaction. Thus, the identified
ASPP2/Par-3 complex is likely to play a positive role in influ-
encing the ability of Par-3 to locate at cell/cell junctions and to
control tight junctionmaturation. Binding to Par-3 and controlling
its cellular localization might, therefore, be a mechanism by
which ASPP2 maintains the integrity of tight junctions and cell
polarity in vitro and in vivo. Failure of Par-3 to correctly locate
apically at the level of tight junctions in epithelial cells may thus
be an underlying reason why tight junction defect and a loss of
cell polarity are the two most prominent features of ASPP2
mutant mice.
ASPP2 was identified originally as a binding partner of p53
(Gorina and Pavletich, 1996; Samuels-Lev et al., 2001) and
subsequently reported to be a common regulator of the p53
family members p63 and p73 (Bergamaschi et al., 2004).
A previous study has shown that the ankyrin repeats of ASPP2
represent a new type of nuclear localization signal and that the
C terminus of ASPP2 alone is nuclear (Sachdev et al., 1998)
(data not shown). However, full-length ASPP2 can be detected
in the cytoplasm, nucleus, and cell/cell junctions in MCF7 cells,
a breast cancer epithelial cell line. Although the location of
endogenous ASPP2 is cell context dependent and the precise
signals that control its localization are largely unknown, ASPP2
locates to cell/cell junctions at an early stage of their formation
in epithelial cells. The function of ASPP2 in controlling cell
polarity is likely to be associated with this localization pattern.c.
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tions and loss of polarity in the CNS is not a known feature of
p53-deficient mice, it is likely that ASPP2’s control of cell polarity
is independent of p53.
The mechanism by which ASPP2 controls cell proliferation
remains unknown. As ASPP2 is a p53-binding protein, its regula-
tion of cell proliferation could involve p53 or its family members.
Signals that translocate ASPP2 from the cell/cell junctions to the
cytoplasm or nucleus may activate p53, p63, or p73 function via
ASPP2. Because the ASPP2/p53 (Vives et al., 2006), ASPP2/
p63, and ASPP2/p73 phenotypes are embryonic lethal (data
not shown), we are currently unable to obtain genetic evidence
to prove whether the newly identified functions of ASPP2 (i.e.,
control of cell polarity and proliferation) are mediated by p53,
p63, or p73. Nonetheless, the potential of ASPP2 to locate at
multiple subcellular localizations places it in a unique position
to act as a bridging molecule to integrate signals between these
different sites.
ASPP2may inhibit cell proliferation through its ability to control
cell polarity independently of the p53 family. A growing body of
evidence suggests that polarity proteins function as mitogens.
Two components of the Scrib complex, Lgl and Dlg, were initially
identified as tumor suppressor genes in Drosophila, and the loss
of either protein results in tumor-like growths in the larval imag-
inal discs and brain (Bilder, 2004; Humbert et al., 2008). Cell
polarity could be linked to proliferation through its ability to regu-
late asymmetric division (Zhong andChia, 2008). Progenitor cells
divide asymmetrically to generate a new progenitor and another
cell that has a more restricted differentiation potential and will
eventually give rise to a terminally differentiated cell. This pro-
cess depends on the establishment of cell polarity that allows
the asymmetric segregation of cell fate determinants. Failure of
cells to successfully divide asymmetrically can lead to an expan-
sion of the progenitor pool and, thus, an increase in cell prolifer-
ation. The expansion of the neural progenitor pool and the
increased proliferation observed in ASPP2 Dexon3 embryos is
compatible with a failure in asymmetric division. Further studies
are, therefore, needed to clarify whether ASPP2 plays a role in
asymmetric division.
In conclusion, our mouse models show that ASPP2 has func-
tions beyond its well-characterized ability to enhance p53-medi-
ated apoptosis. The ability of ASPP2 to regulate cell proliferation
negatively and control the polarity of neural progenitors suggests
a new mechanism by which ASPP2 could function as a tumor
suppressor.
EXPERIMENTAL PROCEDURES
Mouse Colonies
ASPP2 Dexon3 mice were generated in a mixed C57BL/6Jx129SvJ back-
ground (Vives et al., 2006) and backcrossed in a Balb/c background for nine
generations. ASPP2 Dexon3 mice were genotyped using the following
primers: 50-CTCCACCCCAGGAAATTACA-30 (intron3), 50-CGGTTTGGAAGT
CAAAGGAA-30 (exon 3), and 50-GGACCGCTATCAGGACATA-30 (neomycin
resistance gene). ASPP2 Dexon3 conditional mice, in which exon3 was
flanked with LoxP sites, were crossed with R26cre-ERT mice (Vooijs et al.,
2001) to induce exon3 deletion on 4-hydroxytamoxifen treatment.
Generation of cDNA Probes and Whole-Mount In Situ Hybridization
The methodology of Wilkinson was followed (Wilkinson, 1992). Three pairs of
primers were designed against the sequence of mouse ASPP2 cDNA: pair 1Devewas located in exon 4, 50-TCGGAGGAAGGAGAATGGGG-30, and exon 7,
50-CCCTCTGCTTCTGCTGGAACAA-30 (product of 344 bp); pair 2 in exon 1,
50-CTCGTTCTCGCTTGGCTTC-30, and exon 5, 50-TTAGTAGCCAGCATTTG
TTGC-30 (product of 619 bp); and pair 3 in exon 10, 50-TTCCAATGCCGA
CCTCTTAC-30, and exon 12, 50-CTGTTGCTGGGTGTACATGG-30 (product
of 604 bp). Fragments of the expected size were synthesized, ligated into
the pGEM-T Easy vector (Promega), and sequenced to confirm their iden-
tity. All three cDNA probes gave similar results in in situ hybridization
analysis.
Histology and Tissue Section Staining
Embryos at various stages were fixed in 10% buffered formalin overnight (O/N)
or Boins fixative before being dehydrated in an ethanol series, cleared in
Histoclear, and embedded in paraffin wax. For frozen sections, embryos
were fixed O/N in 4% PFA at 4C, cryoprotected in 30% sucrose, embedded
in OCT medium, and snap frozen in dry ice and isopentane. Pup brains were
treated with the same procedure after perfusion with 4% PFA. Sections
were cut at 4 mm thickness for paraffin and 12 mm for frozen sections. Before
immunostaining, rehydrated paraffin-embedded sections were microwaved in
10 mM sodium citrate buffer (pH 6) to unmask the antigen, incubated in 3%
hydrogen peroxide in methanol, washed in PBS, and incubated O/N with the
primary antibody at 4C, followed by either biotinylated or Alexa Fluor
(1:400, Molecular Probes) secondary antibodies for 30 min at room tempera-
ture. Bright light staining was visualized using the peroxide substrate solution
DAB (diaminobenzidine, Vector).
Interkinetic Nuclear Migration and Cell Cycle Length
Pregnant females were injected with a dose of 50 mg/Kg of BrDu and sacri-
ficed after 30 min, 3 hr, or 6 hr. Cell cycle length analysis was carried out as
described in Chenn and Walsh (2002).
Transmission Electron Microscopy (TEM)
Brains were dissected and fixed with 4% glutaraldehyde in cacodylate
buffer, at 4C O/N. After fixation, the brains were sliced coronally. The slices
obtained were postfixed in 1% osmium tetrodoxide in cacodylate buffer for
1 hr, dehydrated in a gradient of alcohol, and embedded in resin. Sections
(1 mm) were cut and analyzed by toluidine blue staining. The area of interest
was trimmed and sections were cut at 0.1 mm thickness and mounted on
a TEM grid.
Culture of Mouse Tubular Kidney Epithelial Cells
For calcium switch experiments, tubular kidney epithelial cells obtained from
ASPP2 Dexon3 conditional knockout mice were grown for 4 days in 24-well
plates on coverglasses (VWR International), with or without 1 mM 4-hydroxyta-
moxifen (Sigma). Cells were then grown for 2 hr in low calcium medium to
disrupt cell/cell junctions, after which normal growth conditions were restored.
Immunocytochemistry was carried out after various time points to detect
E-cadherin and b-catenin. For 3D cultures, tubular kidney epithelial cells
were grown in collagen gels as described for MDCK cells (Elia and Lippin-
cott-Schwartz, 2009) and, on the same day, cells treated with or without
1 mM 4-hydroxytamoxifen. After 3 days in culture, immunocytochemistry
was carried out as described for MDCK cells.
Cell Transfection and Immunocytochemistry
MDCK or MCF7 cells were seeded onto coverglasses (or otherwise stated) in
24-well plates to reach confluency the next day. For transfection experiments,
Lipofectamine 2000 (Invitrogen) was used according to the manufacturer’s
instructions. HKe-3 cells were transfected with siRNA oligos against
ASPP2, or RISC-Free (control), at a final concentration of 35 nM using Dhar-
mafect 1 reagent (Dharmacon) for 3 days, according to the manufacturer’s
instructions.
Once experimental procedures had been carried out, cells were fixed with
4% paraformaldehyde in PBS for 10 min and then permeabilized with 0.1%
Triton X-100 in PBS for 4 min. PBS containing 2% BSA was used as a block-
ing solution for 20 min before incubation with primary antibody. Primary anti-
bodies were diluted in PBS containing 2% of BSA and applied to cells for
40 min. Protein expression was detected using Alexa Fluor (1:400, Molecularlopmental Cell 19, 126–137, July 20, 2010 ª2010 Elsevier Inc. 135
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(1:1000).
Culture of Polarized MDCK Cells and Calcium Switch Assay
MDCK cells were plated on 6.5 mm diameter Transwell filters (Corning) with
a 0.4 mm pore size (105 cells per filter) and grown in DMEM supplemented
with 10% FCS, L-glutamine, and penicillin/streptomycin in a 37C, 10% CO2
incubator. For calcium switch experiments, the medium was changed after
2 days to low calcium medium (DMEM without calcium supplemented with
dialyzed FCS, L-glutamine, and penicillin/streptomycin) for 20 hr and then
replaced with normal calcium growth medium. Immunocytochemistry was
then carried out at various time points.Immunoprecipitation and SDS-PAGE/Immunoblotting
MDCK cells were lysed in buffer containing 50 mM Tris-HCl (pH 8), 150 mM
NaCl, 1 mM EDTA, Complete Protease Inhibitor Cocktail (Roche), and 1%
Triton X-100. P7 pups brains were homogenized and lysed in RIPA buffer.
Lysates were then subjected to immunoprecipitation and SDS-PAGE/immu-
noblotting as described previously. Rabbit polyclonal anti-ASPP2 (S32) was
used to immunoprecipitate ASPP2 and Gal4 rabbit polyclonal antibody (Santa
Cruz Biotechnology) used as a negative control.SUPPLEMENTAL INFORMATION
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